Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1407
Source ID: NCT06389617
Associated Drug: Supraclavicular Block With 20mls Of Ropivacaine 0.5% And Intravenous Administered Dexamethasone
Title: Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block
Acronym:
Status: NOT_YET_RECRUITING
Study Results: NO
Results:
Conditions: End Stage Renal Failure
Interventions: DRUG: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone
Outcome Measures: Primary: To compare the difference of onset time between sensory and motor block of supraclavicular block between ropivacaine with IV dexamethasone 4mg and ropivacaine with IV dexamethasone 8mg, 2 days|To compare the difference in duration of analgesia between supraclavicular block with ropivacaine and IV dexamethasone 4mg with ropivacaine and IV dexamethasone 8mg, 2 days | Secondary: To compare the duration difference of the return of motor block between supraclavicular block using ropivacaine with IV dexamethasone 4mg and ropivacaine with IV dexamethasone 8mg, 2 days
Sponsor/Collaborators: Sponsor: Hospital Universiti Sains Malaysia
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 50
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE
Start Date: 2024-05-01
Completion Date: 2024-12-30
Results First Posted:
Last Update Posted: 2024-04-29
Locations:
URL: https://clinicaltrials.gov/show/NCT06389617